3/17/23 New study shows lack of sleep during the COVID-19 pandemic was associated with high school students’ poor mental health and increased difficulty doing schoolwork.
3/15/23 The U.S. Food and Drug Administration has approved Pfizer Inc.'s zavegepant (Zavzpret), a nasal spray meant to treat severe headache pain, the company announced Friday.